Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed General Assembly
- To Governor
- Became Law
Overview
This bill amends New Jersey’s telehealth regulations to clarify the requirements for prescribing certain Schedule II drugs, such as stimulants for attention-deficit/hyperactivity disorder (ADHD), via telemedicine. It maintains the requirement for an initial in-person examination but reduces the frequency of subsequent in-person visits to every six months for adult patients. The bill also addresses issues related to patient consent, recordkeeping, and professional licensing for providers offering telehealth services.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours